(Q50935530)

English

Reduction of vanadate, a possible explanation of the effect of phenothiazines in manic-depressive psychosis.

scientific article published in February 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

Reduction of vanadate, a possible explanation of the effect of phenothiazines in manic-depressive psychosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

1 reference

based on heuristic

inferred from title

author name string

G G Naylor

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

A H Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

language of work or name

0 references

publication date

1 February 1982

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

8268

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

395-396

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

New approaches to the treatment of manic depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vanadium: a possible aetiological factor in manic depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparative Trial of Imipramine and Chlorpromazine in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Depot injections for affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled comparison of flupenthixol and amitriptyline in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and patient acceptability of intravenous immune globulin in 10% maltose

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2882%2991420-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(82)91420-9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/6120371

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50935530&oldid=1399236130"